← Back to Search

Behavioural Intervention

Remember Stuff: A Dyadic-focused Technology to Support Persons with Alzheimer's Disease in the Community for Caregiver Burnout (R/S Trial)

N/A
Waitlist Available
Led By Nicole R Fowler, PhD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
achieve a Montreal Cognitive Assessment (MoCA) score of 6-17 (mild to moderate dementia)
diagnosis of early Alzheimer's disease or related dementia or caregiver reports ADRD diagnosis (if community based recruitment)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 4 month
Awards & highlights

R/S Trial Summary

This trial is testing a computer monitor to help people with Alzheimer's Disease and their caregivers remember activities of daily living. The goal is to keep participants in their homes longer.

Eligible Conditions
  • Caregiver Burnout
  • Generalized Anxiety Disorder
  • Anxiety
  • Depression

R/S Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

R/S Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 4 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 4 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Usability
Secondary outcome measures
Acceptability
Computer literacy
Intention of Use
+1 more
Other outcome measures
Dementia Severity Scale

R/S Trial Design

1Treatment groups
Experimental Treatment
Group I: 1 Test the usability, perceptions, and acceptability of R/SExperimental Treatment1 Intervention
Dyads will use the R/S unit for 90 days, unless they request it to be removed prior to the end of the study. . The primary outcome is a caregiver-assessed measure usability.

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
976 Previous Clinical Trials
983,347 Total Patients Enrolled
Nicole R Fowler, PhDPrincipal InvestigatorIndiana University
1 Previous Clinical Trials
60 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could I potentially participate in this research investigation?

"Candidates must possess a diagnosis of depression and be between the ages 21 to 95 if they wish to partake in this medical trial. A total of 30 participants are being sought out for enrollment."

Answered by AI

Are enrollment opportunities for this trial currently available?

"According to clinicaltrials.gov, this medical study is not presently recruiting patients; the trial was first posted on October 27th 2020 and last updated August 15th 2022. However, there are currently 2145 other trials actively searching for participants across the world."

Answered by AI

Does the age of 25 serve as an upper limit for participants in this trial?

"The age range for participants of this clinical trial are between 21 and 95. For patients younger than 18, there are 308 studies available while 1712 exist for those older than 65 years old."

Answered by AI
~7 spots leftby Mar 2025